Claire Harrison

Mum, clinician, haematologist, researcher and educator. Views my own. Founder of @MPNVoice and Trustee for @BloodCancerUK

[Claire Harrison @harrisoncn1]

@0DonaldTrumpJr1 16

[Claire Harrison @harrisoncn1]

@MPNSM @MPNVoice we are @GSTT today talking about young people and MPN. An amazing quote from @ClaireWoodley … your MPN does not define your dreams!!

[HemaSphere Journal (prelim IF = 11.3) @Hemasphere_EHA]

What is moving hematology forward?

The June issue of HemaSphere features new @EHA_Hematology recommendations for hemoglobinopathies, advances in #PNH treatment, strategies to improve #CAR T-cell therapy, promising #FL trial results, innovative liquid biopsy research, and new discoveries in #lymphoma and #CLL biology.

Explore the full issue: https://t.co/phSyirGI5X

#openaccess

[Claire Harrison @harrisoncn1]

@MPNSM great news well designed academic trials with embedded science are such an important part of our portfolio alongside commercial and collaborative data collation!

[Dr. Uma Borate: Professor @beatalleukemia]

Kudos to Dr. Coltoff @muschollings for leading the first MPN clinical trial APEX- MF @SWOG & its affiliated sites with @AaronGerds & myself as co-chairs. Excited for this to be an option for #MPN pts across the 🇺🇸. @OSUCCC_James @SupportingSWOG @mpdrc @MPN_Hub @MPN_RF
https://t.co/kS5VyCzqtx

[@onc_ce @onc_ce]

2) Fortunately our intrepid correspondent & returning expert faculty Dr Claire Harrison @harrisoncn1, Prof of Haematology at the Guy’s & St. Thomas’ NHS Foundation Trust @GSTTnhs in #London 🇬🇧was at #EHA2026 and has prepared this update on 🔑data.

[Claire Harrison @harrisoncn1]

Such an exciting EHA

[@onc_ce @onc_ce]

2) Fortunately our intrepid correspondent & returning expert faculty Dr Claire Harrison @harrisoncn1, Prof of Haematology at the Guy’s & St. Thomas’ NHS Foundation Trust @GSTTnhs in #London 🇬🇧was at #EHA2026 and has prepared this update on 🔑data.

[@onc_ce @onc_ce]

1) #EHA2026 in #Stockholm 🇸🇪 is now in the books, but we’re still talking about very exciting presentations on the management of #anaemia in #myelofibrosis #MF that attracted great interest there.

[Claire Harrison @harrisoncn1]

@mpdrc @EHA_Hematology Thanks so much @mpdrc you have always been a role model and great friend.
Very grateful to @EHA_Hematology for the wonderful award it was an overwhelming privilege

[VJHemOnc @VJHemOnc]

Registration is now OPEN for our Post-EHA 2026 Highlights 🩸

Webinar series by VJHemOnc featuring presentations & discussions on selected abstracts from the 31st Congress of the European Hematology Association (EHA)

📍 Webinar series
🗓️ 23 June-2nd July 2026

Covering:
📌 Lymphoma - Chaired by: @KrishPatelMD
📌 MPNs - Chaired by: @harrisoncn1
📌 AML - Chaired by: @Daver_Leukemia
📌 Myeloma - Chaired by: Dr Karthik Ramasamy
📌 MDS - Chaired by: @Dr_AmerZeidan
📌 CLL - Chaired by: Dr Alexey Danilov

Agendas coming soon! 👀

Secure your spot 🔗 👉 https://t.co/j3LipYisY1

[VJHemOnc @VJHemOnc]

Missed our Post-ASH #MPNs webinar? 🤔 Explore the highlights now, including panel discussions where your questions get answered! 🩸 🎥

Featuring presentations & discussions on selected #MPN abstracts from the 67th ASH Annual Meeting and Exposition 💡

Covering:
🔹 Session 1: Advances in the management of PV and ET
🔹 Session 2: Latest in MF therapies
🔹 Session 3: Novel therapeutic approaches for MPNs and #mastocytosis

Chair: @harrisoncn1
Moderators: Francesca Palandri and John Mascarenhas

Give it a watch 👉 https://t.co/lp8fQ0gLd2

#HemOnc

[Claire Harrison @harrisoncn1]

@Hemasphere_EHA Oh thanks team. It’s such a privilege to receive this award not least for having roles I love and working with wonderful people like the @Hemasphere_EHA team.

[Claire Harrison @harrisoncn1]

Proud to be completing the Blood Cancer UK Walk of Light next month. Blood Cancer UK is a hugely important charity supporting major research for Blood Cancer patients worldwide.
Take a look @bloodcancer_uk @MPNSM

https://t.co/HCEZpy6uCa

[@onc_ce @onc_ce]

2) We welcome new expert faculty member, Dr Stephen Oh @mpndoc, Professor of Medicine and Co-Chief @WashUHematology, whose clinical practice and research interests are focused on #myeloproliferative neoplasms, to lead us through the latest.

[@onc_ce @onc_ce]

1) Welcome to a 🆕 CE/#CME-accredited tweetorial, brought to you by the expert faculty of @onc_ce! This program updates data and discussions on #anemia associated with #myelofibrosis #MF from #ASH2025 @ASH_hematology in #Orlando

[@onc_ce @onc_ce]

21a) So what about #luspatercept? @harrisoncn1 taught you about this in https://t.co/CYgI8dsEXc. Luspatercept is a recombinant fusion protein that binds to select transforming growth factor β (#TGF_β) superfamily ligands and enhances late-stage #erythropoiesis.

[MPN_Hub @MPN_Hub]

Learn more about the key findings from a phase I/II study of nuvisertib + momelotinib in patients with R/R MF, presented at #ASH25 with our expert interview, featuring Claire Harrison.

Watch here: https://t.co/mDqujsGBih

#MPN #MPNsm #MedEd @harrisoncn1 @GSTTnhs

[Claire Harrison @harrisoncn1]

Always a joy at ASH to meet fantastic colleagues especially those who will pick up the baton

[Priya Sriskandarajah @PriyaSriRajah]

So important to get this information in order to improve awareness and access to trials - do retweet and spread the word among patients

[@onc_ce @onc_ce]

3a) This tweetorial is accredited for 🆓0.75hr CE/#CME, is intended for #HCPs, & is supported by an educational grant from Bristol Myers Squibb. Statement of accreditation & faculty disclosures are at https://t.co/8oShcATovC. Follow this 🧵 for credit. Follow US for more #MedEd!

[@onc_ce @onc_ce]

2) We welcome new expert faculty member, Dr Claire Harrison @harrisoncn1, clinician, educator, & Prof of Haematology at the Guy’s & St. Thomas’ NHS Foundation Trust @GSTTnhs in London 🇬🇧, where she is also Prof of Myeloproliferative Neoplasms & Deputy Chief Medical Officer